Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces an oral ...
This may seem counterintuitive (if scientists can’t explain something, do they really understand it ... allowing scientists to physically test only the most promising or curiosity-inducing. Wang, a co ...